CHRONIC LIVER DISEASE: DISTRIBUTION AND BIOMARKERS IMPACTS IN EDO STATE

Aim - This study aimed to determine the distribution of chronic liver disease, associated risk factors, and its impact on gamma-glutamyl transferase (GGT) activity and alpha-fetoprotein (AFP) levels in Edo State. Method: Sixty participants were enrolled, comprising 30 diagnosed with liver disease and 30 healthy controls. Patients were recruited from Edo Central Hospital, Benin City, while controls were from the general population. Demographic data were collected via questionnaires, and GGT activity and AFP levels were measured using standard methods. Result - Results revealed significantly higher GGT (81.43 ± 23.94 ng/ml) and AFP (105.97 ± 191.44 ng/ml) levels in patients compared to controls (22.76 ± 10.01 ng/ml and 6.40 ± 23.43 ng/ml, respectively). Most patients were aged 40–59 years (50%), predominantly female, married, and employed. A minority (6.7%) reported a family history of liver disease. Conclusion- Elevated GGT and AFP levels in patients indicate possible cellular destruction due to inflammation, which is a significant indication of liver ailment. Public education on healthy lifestyles and routine medical checks is recommended to mitigate liver disease prevalence and impact.